301 related articles for article (PubMed ID: 17300594)
1. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
2. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
Rosenstock J; Einhorn D; Hershon K; Glazer NB; Yu S;
Int J Clin Pract; 2002 May; 56(4):251-7. PubMed ID: 12074206
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.
Nagi DK; Ali VM; Yudkin JS
Diabet Med; 1996 Aug; 13(8):753-7. PubMed ID: 8862952
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of metformin in type 2 diabetes patients treated with insulin.
Wulffelé MG; Kooy A; Lehert P; Bets D; Oom JA; Borger van der Burg B; Donker AJ; Stehouwer CD
Neth J Med; 2002 Jul; 60(6):249-52. PubMed ID: 12365468
[TBL] [Abstract][Full Text] [Related]
7. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
Ledermann H; Höxter G
Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
Goldenberg R; Gantz I; Andryuk PJ; O'Neill EA; Kaufman KD; Lai E; Wang YN; Suryawanshi S; Engel SS
Diabetes Obes Metab; 2017 Mar; 19(3):394-400. PubMed ID: 28093853
[TBL] [Abstract][Full Text] [Related]
9. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus.
Hermann LS; Bitzén PO; Kjellström T; Lindgärde F; Scherstén B
Diabete Metab; 1991 May; 17(1 Pt 2):201-8. PubMed ID: 1936477
[TBL] [Abstract][Full Text] [Related]
11. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
Koch HH; Wudy A; Eberlein G; Quast C
Diabetes Nutr Metab; 1999 Jun; 12(3):195-201. PubMed ID: 10554902
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, tolerability and safety of nateglinide in combination with metformin. Results from a study under general practice conditions.
Schatz H; Schoppel K; Lehwalder D; Schandry R
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):262-6. PubMed ID: 12951631
[TBL] [Abstract][Full Text] [Related]
13. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
Hermann LS; Melander A
Lakartidningen; 1999 Dec; 96(50):5616-9. PubMed ID: 10643226
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study.
Dagogo-Jack S; Liu J; Eldor R; Amorin G; Johnson J; Hille D; Liao Y; Huyck S; Golm G; Terra SG; Mancuso JP; Engel SS; Lauring B
Diabetes Obes Metab; 2018 Mar; 20(3):530-540. PubMed ID: 28921862
[TBL] [Abstract][Full Text] [Related]
15. Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial.
Schernthaner G; Gross JL; Rosenstock J; Guarisco M; Fu M; Yee J; Kawaguchi M; Canovatchel W; Meininger G
Diabetes Care; 2013 Sep; 36(9):2508-15. PubMed ID: 23564919
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.
Saxena T; Maheshwari S; Goyal RK
J Assoc Physicians India; 2000 Aug; 48(8):815-7. PubMed ID: 11273476
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.
Levy J; Atkinson AB; Bell PM; McCance DR; Hadden DR
Diabet Med; 1998 Apr; 15(4):290-6. PubMed ID: 9585393
[TBL] [Abstract][Full Text] [Related]
18. Effect of acarbose in treatment of type II diabetes mellitus: a double-blind, crossover, placebo-controlled trial.
Soonthornpun S; Rattarasarn C; Thamprasit A; Leetanaporn K
J Med Assoc Thai; 1998 Mar; 81(3):195-200. PubMed ID: 9623011
[TBL] [Abstract][Full Text] [Related]
19. One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.
Campbell IW; Menzies DG; Chalmers J; McBain AM; Brown IR
Diabete Metab; 1994; 20(4):394-400. PubMed ID: 7843470
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial.
Pratley RE; Nauck MA; Bailey T; Montanya E; Filetti S; Garber AJ; Thomsen AB; Furber S; Davies M;
Diabetes Care; 2012 Oct; 35(10):1986-93. PubMed ID: 22851600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
